The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
 
 
 
 

Z-4',5'-didehydro-5'-deoxy-5'-fluoroadenosine (MDL 28,842), an irreversible inhibitor of S-adenosylhomocysteine hydrolase, suppresses proliferation of cultured keratinocytes and squamous carcinoma cell lines.

S-Adenosylmethionine-dependent transmethylation reactions are required for many critical pathways in human cells. The enzyme S-adenosylhomocysteine hydrolase converts S-adenosylhomocysteine, a potent endogenous inhibitor of S-adenosylmethione-mediated methyltransferase reactions, to adenosine and L-homocysteine. The effects of the inhibitor of S-adenosylhomocysteine hydrolase, Z-4',5'-didehydro-5'-deoxy-5'-fluoroadenosine (MDL 28,842), on the growth of cultured keratinocytes and cutaneous squamous cell carcinoma lines were investigated. MDL 28,842 suppressed the proliferation of all cells in a dose-dependent manner, and significantly increased keratinocyte differentiation at a concentration of 1 microM. Following incubation with MDL 28,842, the methylation indices (ratio of S-adenosylmethionine/S-adenosylhomocysteine) of undifferentiated keratinocytes and squamous cell carcinoma lines were significantly decreased. These data demonstrate that the inhibitory effect of MDL 28,842 on squamous carcinoma cells and keratinocyte proliferation may result directly from inhibition of S-adenosylhomocysteine hydrolase activity. The antiproliferative activity of MDL 28,842 against squamous carcinoma cells and keratinocytes suggests a potential role for MDL 28,842 as a novel therapeutic agent for neoplastic and hyperproliferative disorders of the skin.[1]

References

 
WikiGenes - Universities